chalcone has been researched along with Epithelial Ovarian Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Astuti, I; Bamodu, OA; Huang, WC; Lee, WH; Lin, CM; Su, YK; Suwito, H; Yeh, CT; Zucha, MA | 1 |
1 other study(ies) available for chalcone and Epithelial Ovarian Cancer
Article | Year |
---|---|
Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication.
Topics: Apoptosis; Autophagy; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Chalcone; Cisplatin; DNA Damage; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Ovarian Neoplasms; Phosphorylation | 2017 |